Panagora Asset Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Panagora Asset Management’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-443	Closed	-$1K	–	1857
2021 Q2	$1K	Sell	443 -23	-5%	-$68	﹤0.01%	2681
2021 Q1	$1K	Hold	466	–	–	﹤0.01%	2757
2020 Q4	$1K	Sell	466 -92	-16%	-$279	﹤0.01%	2708
2020 Q3	$2K	Hold	558	–	–	﹤0.01%	2576
2020 Q2	$2K	Hold	558	–	–	﹤0.01%	2467
2020 Q1	$2K	Hold	558	–	–	﹤0.01%	2384
2019 Q4	$3K	Hold	558	–	–	﹤0.01%	2315
2019 Q3	$3K	Buy	+558	New	+$3.1K	﹤0.01%	2345

Other funds holding CPIX

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAM

Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFP

Sterling Financial Planning Sparta, New Jersey $337M AUM 19.27% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Panagora Asset Management's CPIX Position: Q3 2021 in Review

Panagora Asset Management sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2021, closing a stake of 443 shares — an estimated $1K sold.

Panagora Asset Management first reported a position in CPIX in Q3 2019 and held it in 8 quarters. The position peaked at $3K in Q4 2019. 23 funds tracked by Wall St. Rank hold CPIX as of Q3 2021.

Panagora Asset Management reported no remaining Cumberland Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Panagora Asset Management sold 443 Cumberland Pharmaceuticals shares in Q3 2021, an estimated $1K.
Panagora Asset Management first reported a position in Cumberland Pharmaceuticals in Q3 2019 and held it in 8 quarters.
Panagora Asset Management's Cumberland Pharmaceuticals position peaked at $3K in Q4 2019.
23 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.